Announcement PDF RNS Number : 9432J Valereum PLC 29 October 2024 29/10/2024 Valereum Plc ("Valereum" or the "Company") Valereum Plc to Present at Aquis Showcase Event Valereum Plc (AQSE: VLRM), a fintech company seeking to unlock capital and create value in tokenised digital markets, both as a leading technology provider and as a marketplace operator, is pleased to announce it will be presenting at the Aquis Stock Exchange Showcase on Tuesday, 12th November 2024 in London. The Aquis Showcase Event is a one-day event with companies presenting and competing in an investment contest, to be judged by a panel of experts. Join us to hear CEO Nick Cowan deliver an 8-minute pitch, followed by a rapid-fire Q&A session. This is a great chance to catch up on our latest updates and connect with our management team in person. Existing and potential shareholders are encouraged to attend the event and watch the presentation. For further information on the event and how to purchase tickets, please visit: Aquis Showcase 2024 For further information, please contact: Enquiries: Valereum Plc James Formolli, Chairman Tel: +44 7938 767319 Stanford Capital Partners Bob Pountney Patrick Claridge Tel: +44 023 3650 3650 AQSE Corporate Adviser First Sentinel Corporate Finance Brian Stockbridge Tel: +44 20 3855 5551 Further updates to follow in due course. The directors of the Company accept responsibility for the contents of this announcement. For more information, please visit the Company's website at www.vlrm.com This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END NRAEAPEPALLLFFA